Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new?

In conclusion, considering the modest survival gain obtained overall, the high cost of these therapies and the quality of life issue must be primarily considered in treating these patients.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research